Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rate Control in Atrial Fibrillation II
NCT02695992Phase 4Completed
- Sponsor
- Bærum Sykehus
- Start
- Feb 2016
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diltiazem in Atrial fibrillation (AFib), sponsored by Bærum Sykehus. Started Feb 2016; status: completed.
02
Drugs
diltiazem
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02695992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695992.